Gavreto savings card: as little as $0 a prescription with commercial insurance

How to pay the least

Ask for the cash price

Gavreto

We didn’t find one.

Ask your pharmacy for Gavreto’s cash price, and one or two other pharmacies too.
Gavreto’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameGavreto

Authorized genericpralsetinib

Regular genericpralsetinib

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldNone found

Same as Gavreto?

The original

–

Brand nameThe maker’s card

GAVRETO Copay Assistance Program (RIGEL ONECARE)

Savings card from Rigel Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a prescription

Or call 1-833-744-3562.

In the maker’s words

“Eligible patients with commercial insurance pay as little as $0 per prescription fill with the GAVRETO copay assistance program.”

From the maker’s offer on rigelonecare.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Gavreto itself, from the same company, sold without the brand name, and usually for less. For now Gavreto is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

GAVRETO is a kinase inhibitor indicated for treatment of:

Adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer as detected by an FDA approved test (NSCLC).
Adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and who are radioactive iodine-refractory (if radioactive iodine is appropriate). This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s).

Source: the FDA label for Gavreto (Rigel Pharmaceuticals, Inc.), December 30, 2025. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/gavreto/